[The copyright line for this article was changed on 11 July 2014 after original online publication.]
Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda
Version of Record online: 7 APR 2014
© 2014 Wiley-Liss, Inc., A Wiley Company. Pediatric Blood & Cancer published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Pediatric Blood & Cancer
Volume 61, Issue 9, pages 1551–1557, September 2014
How to Cite
Vassal, G., Fitzgerald, E., Schrappe, M., Arnold, F., Kowalczyk, J., Walker, D., Hjorth, L., Riccardi, R., Kienesberger, A., Jones, K.-P., Valsecchi, M. G., Janic, D., Hasle, H., Kearns, P., Petrarulo, G., Florindi, F., Essiaf, S. and Ladenstein, R. (2014), Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda. Pediatr. Blood Cancer, 61: 1551–1557. doi: 10.1002/pbc.25044
Conflict of interest: Nothing to declare.
- Issue online: 17 JUL 2014
- Version of Record online: 7 APR 2014
- Manuscript Accepted: 3 MAR 2014
- Manuscript Received: 14 DEC 2013
In Europe, 6,000 young people die of cancer yearly, the commonest disease causing death beyond the age of 1 year. In addition, 300,000–500,000 European citizens are survivors of a childhood cancer and up to 30% of them have severe long-term sequelae of their treatment. Increasing both cure and quality of cure are the two goals of the European paediatric haematology/oncology community. SIOPE coordinates and facilitates research, care and training which are implemented by the 18 European study groups and 23 national paediatric haematology/oncology societies. SIOPE is the European branch of the International Society of Paediatric Oncology and one of the six founding members of the European Cancer Organisation. SIOPE is preparing its strategic agenda to assure long-term sustainability of clinical and translational research in paediatric malignancies over the next 15 years. SIOPE tackles the issues of equal access to standard care and research across Europe and improvement of long term follow up. SIOPE defined a comprehensive syllabus for training European specialists. A strong partnership with parent, patient and survivor organisations is being developed to successfully achieve the goals of this patient-centred agenda. SIOPE is advocating in the field of EU policies, such as the Clinical Trials Regulation and the Paediatric Medicine Regulation, to warrant that the voice of young people is heard and their needs adequately addressed. SIOPE and the European community are entirely committed to the global agenda against childhood cancers to overcome the challenges to increasing both cure and quality of cure of young people with cancer. Pediatr Blood Cancer 2014;61:1551–1557. © 2014 Wiley-Liss, Inc., A Wiley Company. Pediatric Blood & Cancer published by Wiley Periodicals, Inc.